Hepatitis C Virus Infection Completed Phase 2 Trials for Vedroprevir (DB12037)

Indication	Status	Phase
DBCOND0033268 (Hepatitis C Virus Infection)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02226549	Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis	Treatment	Ledipasvir (DB09027) Ribavirin (DB00811) Sofosbuvir (DB08934) Vedroprevir (DB12037)